Table 2.
Joint Susceptibility Genes for T1D and AITD
| Gene | Chromosome | Function |
|---|---|---|
| Confirmed joint susceptibility genes | ||
| HLA class II genes | 6 | Presents autoantigens to T cells |
| PTPN22 | 1 | Negatively influences T cell receptor signaling pathway |
| CTLA-4 | 2 | Suppresses T cell activation |
| FOXP3 | X | Controls differentiation of regulatory T cells |
| Candidate susceptibility genes | ||
| IL-1RA | 2 | Implicated in pathogenesis of autoimmune diseases |
| IL-4 | 5 | Implicated in Th2 humoral immunity |
| MICA | 6 | NKG2D receptors stimulate NK cells and T cell effector functions |
| TNF-α | 6 | Implicated in pathogenesis of autoimmune diseases |
| Tg | 8 | Represents a major target of the immune response in AITD |
| IL2RA/CD25 | 10 | Impacts production and function of regulatory T cells |
| VNTR (insulin) | 11 | Alters transcription of the insulin gene |
| ERBB3 | 12 | Not defined |
| CLEC16A | 16 | Implicated in pathogen recognition |
| CD40 | 20 | Interacts with CD40 ligand on T cells |
Abbreviations: CD40, B cell–associated molecule CD40; CLEC16A, C-type lectin domain family 16 member A; ERBB3, v-erb-b2 erythroblast leukemia viral oncogene homolog 3; IL-1RA, IL-1 receptor antagonist; IL2RA, IL-2Rα; MICA, MHC class I chain-related gene A; NK, natural killer; NKG2, NK cell group 2 (group of genes that are expressed primarily in NK cells encoding a family of C-type lectins; the NKG2D gene is expressed as a major 1.8-kb and a minor 3.2-kb transcript in NK cell lines and in some T cell lines); Tg, thyroglobulin; VNTR (insulin), insulin gene variable number of an 86-tandem repeat [a penta-allelic 86-bp tandem repeat (VNTR) occurs in intron 2, of which allele 2 (IL1RN*2) is associated with autoimmune conditions].